Bristol-Myers Squibb stock backed by Goldman Sachs as Cobenfy's unique safety profile sets it apart

Sep 29, 2024 - 00:00
Bristol-Myers Squibb stock backed by Goldman Sachs as Cobenfy's unique safety profile sets it apart

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow